AC Immune (ACIU) Share-based Compensation Growth (1y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 206.26% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -69.95% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.18% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.66% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 23.70% |
| 10 | AC Immune | 325.88 Mn | 211.53 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.46% |
| Sep 30, 2025 | -28.18% |
| Jun 30, 2025 | -12.22% |
| Mar 31, 2025 | -19.63% |
| Dec 31, 2024 | 22.85% |
| Sep 30, 2024 | 44.16% |
| Jun 30, 2024 | 12.86% |
| Mar 31, 2024 | 35.48% |
| Dec 31, 2023 | -2.63% |
| Sep 30, 2023 | 70.80% |
| Jun 30, 2023 | 46.76% |
| Mar 31, 2023 | 48.61% |
| Dec 31, 2022 | -18.57% |
| Sep 30, 2022 | -61.96% |
| Jun 30, 2022 | 1.47% |
| Mar 31, 2022 | 12.98% |
| Dec 31, 2021 | 1.54% |
| Sep 30, 2021 | 12.87% |
| Jun 30, 2021 | -11.11% |
| Mar 31, 2021 | 7.61% |
| Dec 31, 2020 | 36.88% |
| Sep 30, 2020 | 49.51% |
| Jun 30, 2020 | 84.57% |
| Mar 31, 2020 | 50.22% |
| Dec 31, 2019 | 30.67% |
| Sep 30, 2019 | 51.07% |
| Jun 30, 2019 | -22.65% |
| Mar 31, 2019 | -7.62% |
| Dec 31, 2018 | 100.07% |
| Sep 30, 2018 | -99.93% |
| Jun 30, 2018 | 256.34% |
| Mar 31, 2018 | 537.33% |
| Dec 31, 2017 | -86,301.50% |
| Sep 30, 2017 | 556,660.48% |
| Jun 30, 2017 | 96.97% |
| Mar 31, 2017 | 160.30% |
| Dec 31, 2016 | 1,578.85% |